

Retiring @40: Freedom, Fantasy, Or Financial Strategy?
As burnout, financial independence, and changing definitions of success reshape careers, a growing number of professionals are discovering that the real goal isn't retirement but reclaiming control over time, work and life.How next-gen factories could make India a manufacturing powerhouse
India may have joined the manufacturing race late, but a new generation of factories could help it leapfrog into global competitiveness.How REITs are becoming a rewarding investment proposition
As GCCs fuel demand for premium workspaces and malls continue to attract footfalls, REITs are turning commercial real estate into a rewarding investment proposition.Why the Bharat Maritime Insurance falls short of competitive offerings and coverage
The Bharat Maritime Insurance Pool for Indian flagged vessels aims to offer uninterrupted risk coverage in conflict situation. However, it falls short of competitive offerings and coverage.How India Inc's balance sheets are improving, despite moderate revenue growth
India Inc is now reporting stronger profitability and improving balance sheets. But revenue growth has moderated.Can India secure a place in quantum computing?
Quantum computing may be years away from large-scale deployment, but can India secure a place in the sun?What the BT-C Fore Business Confidence Index says about India Inc’s mood
India Inc's mood has plummeted to a record low as per the BT-C Fore Business Confidence Index for the second quarter of the fiscal. Will peace in West Asia improve sentiment?How Zaynich will drive Wockhardt’s next phase of growth
After spending nearly Rs 6,800 crore and more than two decades, Wockhardt has achieved what no Indian pharmaceutical company has before: US FDA approval for a novel drug discovered and developed in-house. Zaynich is expected to drive Wockhardt's next phase of growth after it returned to profitability in FY26.

